NOVOSITE THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 17 Feb 2025)
What this means for you
This application is over — abandoned 23 Jan 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98480811
- Mark type
- Stylized text
- Filed
- 02 Apr 2024
- Abandoned
- 23 Jan 2025
- Attorney of record
- Alyssa M. Worsham
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development in the field of genome engineering; research and development in functional genomics for use in the fields of immunology and inflammation; medical research for use in conducting in-cell, endogenously contextualized deep mutational scanning in the field of genomics; medical and scientific research; medical and scientific research, namely, screening cell phenotypes; pharmaceutical research for small molecule drug discovery and development; pharmaceutical research, namely, research relating to genomics for improving pharmacological properties; pharmaceutical research, namely, research relating to genomics for use in connection with a wide variety of therapeutic agents; medical and scientific research for use in the fields of immunology and inflammation; pharmaceutical research for small molecule drug discovery and development for use in the fields of immunology and inflammation
Owner
- Site TX, Inc., Dover, DE, US
Prosecution history
- 17 Feb 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 17 Feb 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 22 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Oct 2024 — NON-FINAL ACTION E-MAILED
- 22 Oct 2024 — NON-FINAL ACTION WRITTEN
- 16 Oct 2024 — ASSIGNED TO EXAMINER
- 08 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Apr 2024 — NEW APPLICATION ENTERED